We are mission-focused on developingone-time treatments for genetic disorders We are partners to the rare disease community Learn about our Clinical Trials >>> We Are Applying our Broad Genetic Medicines Platform to Treat, or Cure, Genetic Disease Learn About Our Platform >>> View Our Pipeline >>> Recent News >>> August 14, 2023Homology Medicines Reports Second Quarter 2023 Financial Results and Recent HighlightsJuly 27, 2023Homology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKUJuly 27, 2023Homology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKU We are Homology Learn about our Team and Mission >>>
